Skip to main content

Emergent BioSolutions doubles capacity at Baltimore plant – FiercePharma

By May 10, 2017News
emergent-biosolution-logo

emergent-biosolution-logo

Emergent BioSolutions is one of the vaccine producers that the federal government can tap in case of a virus pandemic, and now it has doubled the size of one of its manufacturing and development facilities with funding help from the feds.

{iframe}http://www.fiercepharma.com/manufacturing/emergent-biosolutions-doubles-capacity-at-baltimore-plant{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.